TITLE

Auditor general targets Health Canada spending

AUTHOR(S)
Kondro, Wayne
PUB. DATE
February 2002
SOURCE
CMAJ: Canadian Medical Association Journal;2/5/2002, Vol. 166 Issue 3, p365
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports Canada's auditor general Sheila Fraser's criticisms of Health Canada. Assertion that the organization uses no formal process for making decisions on program priorities and often breaks its own rules in granting funds; Audit of projects funded by Health Canada; How a Wellness Framework was developed but not implemented.
ACCESSION #
6073931

 

Related Articles

  • Auditor-General slams regulatory regime. Kondro, Wayne // CMAJ: Canadian Medical Association Journal Supplement;1/2/2007, Vol. 176 Issue 1, p22 

    The article reports on the criticisms of Auditor-General Sheila Fraser to the management of the regulatory programs of Health Canada. Fraser questioned Health Canada's process and principles for the management of its regulatory program. She added that such deficient management would likely...

  • Auditor-General critical of Health Canada regulatory performance. Garmaise, David // HIV/AIDS Policy & Law Review;May2007, Vol. 12 Issue 1, p27 

    The article reports on the comment of the Sheila Fraser, the Auditor-General of Canada, on the performance of Health Canada in 2006. Fraser said that Health Canada had not been successful in setting performance targets for all of its regulatory programs. She added that the funding remains...

  • THE ROLE OF THE OFFICE OF THE AUDITOR GENERAL IN CANADA AND THE CONCEPT OF INDEPENDENCE. Fraser, Sheila // Canadian Journal of Program Evaluation;Spring2006, Vol. 21 Issue 1, p1 

    The article presents a speech by Sheila Fraser, auditor general of Canada, given before the joint meeting of the Canadian Evaluation Society and the American Evaluation Association in Toronto, Ontario in October 2005. She discusses the role of the auditor general, the concept of independence and...

  • Chief interpreter. Cosh, Colby // Report / Newsmagazine (National Edition);02/05/2001, Vol. 28 Issue 3, p14 

    Reports on the appointment of Kevin Keough to the position of chief scientist for Health Canada, as of February, 2001. How Keough, a biochemist at the Memorial University of Newfoundland, will act as a liaison between scientists and policy-makers and will defend the interests of scientists...

  • Chief interpreter. Cosh, Colby // Report / Newsmagazine (BC Edition);02/05/2001, Vol. 28 Issue 3, p14 

    Reports on the appointment of Kevin Keough to the position of chief scientist for Health Canada, as of February, 2001. How Keough, a biochemist at the Memorial University of Newfoundland, will act as a liaison between scientists and policy-makers and will defend the interests of scientists...

  • Chief interpreter. Cosh, Colby // Report / Newsmagazine (Alberta Edition);02/05/2001, Vol. 28 Issue 3, p14 

    Reports on the appointment of Kevin Keough to the position of chief scientist for Health Canada, as of February, 2001. How Keough, a biochemist at the Memorial University of Newfoundland, will act as a liaison between scientists and policy-makers and will defend the interests of scientists...

  • FDA, Health Canada, tout benefits of PMAP.  // Medical Device Daily;11/12/2010, Vol. 14 Issue 221, p9 

    The article reports on the results of the joint pilot multipurpose audit program of the U.S. Food and Drug Administration (FDA) and Health Canada which suggests that industry can shave off a substantial number of inspection/audit days from calendars by taking part in such programs in the future.

  • Canada Vigilance: a new name and database.  // WHO Drug Information;2008, Vol. 22 Issue 1, p18 

    The article announces the Canada Vigilance as the new name of the Canadian Adverse Drug Reaction Monitoring Program of the government health agency Health Canada in Canada in 2008. The program also implement its new database that will provide an enhanced capacity for the postmarketing...

  • Enzyme therapy for Fabry patients in jeopardy. Silversides, Ann // CMAJ: Canadian Medical Association Journal;9/15/2009, Vol. 181 Issue 6/7, pE120 

    The article reports on the decision of the Health Canada not to extend its funding for the Canadian Fabry Disease Initiative Enzyme Replacement Study in 2009. A physicians says that it will put the treatment an uncertain future. He asserts that without the federal support, it is unclear whether...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics